Table 1.
Class | C3 Protein | Ligand(s) | PDB IDa,b | Resolution (Å) |
Authors | Citation |
---|---|---|---|---|---|---|
C3 Proper | C3 | - | 2A73 | 3.3 | Janssen et al. | [12] |
C3a | 4HW5 | 2.3 | Bajic et al. | [86] | ||
C3b | - | 2I07 | 4.0 | Janssen et al. | [15] | |
C3b | - | 5F07 | 2.8 | Forneris et al. | [43] | |
iC3b1 | hC3Nb1 | 6YO6 | 6.0 | Jensen et al. | [87] | |
C3c | - | 2A74 | 2.4 | Janssen et al. | [12] | |
C3d | - | 1C3D | 1.8 | Nagar et al. | [88] | |
C3 convertase | C3b | Factor B | 2XWJ | 4.0 | Forneris et al. | [24] |
C3b | Factor B Factor D |
2XWB | 3.5 | Forneris et al. | [24] | |
C3b | Factor Bb S. aureus SCIN |
2WIN | 3.9 | Rooijakkers et al. | [33] | |
C3b | Factor Bb Factor P, monomeric formc S. aureus SCIN |
6RUR | 6.0 | Pedersen et al. | [35] | |
C345c | Factor P, monomeric formd | 6S0B | 2.3 | van den Bos et al. | [36] | |
Regulators | C3b | MCP, CCP(1-4) | 5FO8 | 2.4 | Forneris et al. | [43] |
C3b | CR1, CCP(15-17) | 5FO9 | 3.3 | Forneris et al. | [43] | |
C3b | DAF, CCP(2-4) | 5FOA | 4.2 | Forneris et al. | [43] | |
C3b | Factor H, CCP(1-4) | 2WII | 2.7 | Wu et al. | [44] | |
C3d | Factor H, CCP(19-20) | 2XKW 3OXU |
2.3 2.1 |
Kajander et al. Morgan et al. |
[89] [90] |
|
C3b | mini-FHe, CCP(1-4)+(19-20) | 5O32 | 4.2 | Xue et al. | [46] | |
C3b | mini-FHe, CCP(1-4)+(19-20) Factor I | 5O35 | 4.2 | Xue et al. | [46] | |
Receptors | C3c | CRIg, Ig(1) | 2ICE | 3.1 | Wiesmann et al. | [23] |
C3b | CRIg, Ig(1) | 2ICF | 4.1 | Wiesmann et al. | [23] | |
iC3b | CR3, I-domain | 7AKK | 3.4 | Fernandez et al. | [58] | |
C3d | CR2, CCP(1-2) | 3OED | 3.2 | van den Elsen et al. | [55] | |
C3d | CR3, I-domain | 4M76 | 2.8 | Bajic et al. | [57] | |
Inhibitors | C3b | Variola virus SPICE, CCP(1-4) | 5FOB | 2.6 | Forneris et al. | [43] |
C3c | S. aureus SCIN | 3OHX | 3.5 | Garcia et al. | [22] | |
C3c | S. aureus SCIN-B | 3T4A | 3.4 | Garcia et al. | [66] | |
C3b | S77, Fab fragment | 3G6J | 3.1 | Katschke et al. | [68] | |
C3b | hC3Nb1 | 6EHG | 2.7 | Jensen et al. | [67] | |
C3c | Compstatin, 4W9A | 2QKI | 2.4 | Janssen et al. | [75] | |
C3b | Compstatin, Cp40 | 7BAG | 2.0 | Lamers et al. | [74] | |
C3d | S. aureus Efb-C | 2GOX | 2.2 | Hammel et al. | [18] | |
C3d | S. aureus Ehp | 2NOJ | 2.7 | Hammel et al. | [19] | |
C3d | S. aureus Sbi, Domain IV | 2WY7 2WY8 |
1.7 | Clark et al. | [21] | |
C3d | Factor H, CCP(19-20) B. burgdorferi OspE |
5NBQ | 3.2 | Kolodziejczyk et al. | [91] |
As of this writing, there are 54 unique PDB depositions of crystal structures containing various forms of human C3.
In general, only the first report of a structure determination is highlighted in this Table. However, certain structures representing particularly important features or significant improvements in either resolution or model quality are also included. Structures representing alternative crystal forms, site-directed mutants, or various ligands when unbound to C3 or its fragments are omitted in the interest of space.
Further information on the nature and characterization of the monomeric form of properdin may be found in the publication of Pedersen et al. [34].
Further information on the nature and characterization of the mini-FH protein may be found in the original manuscript by Schmidt et al. [47].